The evolution and clinical impact of hepatitis B virus genome diversity
Peter A Revill, Thomas Tu, Hans J Netter, Lilly KW Yuen, Stephen A Locarnini, Margaret Littlejohn
Nature Reviews Gastroenterology & Hepatology | NATURE RESEARCH | Published : 2020
The global burden of hepatitis B virus (HBV) is enormous, with 257 million persons chronically infected, resulting in more than 880,000 deaths per year worldwide. HBV exists as nine different genotypes, which differ in disease progression, natural history and response to therapy. HBV is an ancient virus, with the latest reports greatly expanding the host range of the Hepadnaviridae (to include fish and reptiles) and casting new light on the origins and evolution of this viral family. Although there is an effective preventive vaccine, there is no cure for chronic hepatitis B, largely owing to the persistence of a viral minichromosome that is not targeted by current therapies. HBV persistence ..View full abstract
Awarded by German Centre for Infection Research (DZIF), TTU Hepatitis Projects
Awarded by Deutsche Forschungsgemeinschaft (DFG)
T.T. is financially supported by the German Centre for Infection Research (DZIF), TTU Hepatitis Projects 5.807 and 5.704, the Deutsche Forschungsgemeinschaft (DFG) TRR179 (TP 15 and the Australian Centre for HIV and Hepatitis Virology Research). The authors thank R. Schinazi for providing helpful information on capsid inhibitors.